Found: 9
Select item for more details and to access through your institution.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 601, doi. 10.1007/s40264-024-01419-3
- By:
- Publication type:
- Article
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 607, doi. 10.1007/s40264-024-01422-8
- By:
- Publication type:
- Article
Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 617, doi. 10.1007/s40264-024-01415-7
- By:
- Publication type:
- Article
The Role of Mitochondria in Statin-Induced Myopathy.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 643, doi. 10.1007/s40264-024-01413-9
- By:
- Publication type:
- Article
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE).
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 655, doi. 10.1007/s40264-024-01417-5
- By:
- Publication type:
- Article
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 673, doi. 10.1007/s40264-024-01418-4
- By:
- Publication type:
- Article
Fatal Intoxications with Zopiclone—A Cause for Concern?
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 687, doi. 10.1007/s40264-024-01424-6
- By:
- Publication type:
- Article
Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 699, doi. 10.1007/s40264-024-01425-5
- By:
- Publication type:
- Article
The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 711, doi. 10.1007/s40264-024-01427-3
- By:
- Publication type:
- Article